A treatment option for Medication-resistant depression
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: adult patients with the relapse of major depressive episode
Exclusion criteria
Exclusion criteria: Patients with schizophrenia, organic mental disorder and major physical illness; with brain implants or cardiac pacemakers; pregnancy; or who having strong suicidal risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the changing of HDRS-17 (week-2 vs. baseline) in response to the 2-week prefrontal brain stimulation | — |
Secondary
| Measure | Time frame |
|---|---|
| Computerized rACC-engaging cognitive tasj(RECT); EEG; Maudsley Staging method for refractoriness; response rate; the changing of HDRS-17 of the 12-week follow-up after the treatment (week-14 vs. baseline) in response to the 2-week brain stimulation; Young mania Rating scale; Clinical Global Index; Depression and somatic symptoms; Life stress scale; the comparison for localization between" 5 cm rule" and MRI neuro-navigation. | — |
Countries
Asia(except Japan)
Contacts
Taipei Veterans General Hospital, Taiwan Psychiatry